For nearly two years, the corneal cross-linking for the treatment of keratoconus can be successfully performed without removing the corneal epithelium. Indeed, the removal of the epithelium is the only drawback of the traditional cross-linking and is the leading cause of complications, albeit infrequent, related to the procedure.
Dr. Marco Lombardo took part in the pre-clinical validation of the transepithelial corneal cross-linking with iontophoresis. To date, is among ophthalmologists to have a longer series of patients treated with this technique in the world. At one year from the treatment, the majority of patients treated shows a reduction of the curvature of the cone apex comparable to that obtained with the traditional treatment. In addition, cross-linking with iontophoresis allows a slight improvement of visual acuity in almost all patients, in contrast to the standard treatment that achieves these results in just 20% of patients.